Synopsys drew higher Wall Street price targets after its September 30, 2026 Investor Day, where management presented a growth framework that exceeded some analysts' expectations. BofA raised its target to $600 from $500 and retained its buy rating, while KeyBanc increased its target to $605 from $600 and maintained its overweight rating. The analysts cited projected pro-forma EPS compound annual growth of 23% from FY26-30, stronger initial FY27 guidance, higher long-term electronic design automation (software for designing electronic chips) and silicon IP (reusable semiconductor design building blocks) growth targets, margin expansion, and new partnerships with OpenAI and AWS. Synopsys also reported fiscal Q3 2026 revenue of $2.48 billion and non-GAAP EPS of $3.91, then raised its full-year guidance to $9.69 billion-$9.74 billion in revenue and $15.04-$15.10 in non-GAAP EPS. Shares were $475.70 Thursday morning, up 9.37% on the session and 15.16% over the past week. The outlook remains subject to export controls, tariffs, customer concentration, Ansys integration and restructuring charges, with the next test coming in Q4.